NRSN Reports Positive Biomarker Findings
NeuroSense reports positive biomarker findings from Phase 2 RoAD proof-of-concept study of PrimeC in Alzheimer's disease
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.